mRNA Sequencing Market Rapidly Increasing In Size Globally (2020-2025) and Market Analysis by Top Key Vendors (GE, Roche, Thermo Fisher, Illumina, QIAGEN, Agilent, Bio-Rad Lab, Fluidigm)

Global mRNA Sequencing Market Synopsis:

The report covers a forecast and an analysis of the mRNA Sequencing Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the mRNA Sequencing Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the mRNA Sequencing Market on a global level.

The major key factors driving the growth of the Global mRNA Sequencing Market are advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/253062 .

In terms of the geographic analysis, North America accounted for the largest share of the mRNA Sequencing Market in 2018. This can primarily be attributed to the government support through funds for genomics research, advancements in RNA-Seq products, growing prevalence of target diseases, growing research on cancer and inherited rare diseases, and the strong presence of key players.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global mRNA Sequencing Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Thermo Fisher Scientific

2 Illumina

3 QIAGEN (Exiqon)

4 Agilent Technologies

5 Roche

6 GE Healthcare

7 Bio-Rad Laboratories

8 Fluidigm and More…………………

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global mRNA Sequencing Market Report 2020” @ https://www.businessindustryreports.com/buy-now/253062/single .

Product Type Segmentation

1 PCR

2 Microarray

3 Sequencing

Industry Segmentation

1 Pharmaceutical and Biotechnology

2 Academic Research and Government Institutes

3 Hospitals and Diagnostic Centers

On the basis of Regional analysis, North America and Europe holds major share in global mRNA Sequencing market. Moreover, Asia-Pacific is expected to record higher growth rate in mRNA Sequencing Market during the forecast year.

Latest Medical Industry News:

Roche (March 19, 2020) - Roche initiates Phase III clinical trial of Actemra / RoActemra in hospitalised patients with severe COVID-19 pneumonia - Roche today announced  we are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR), to evaluate the safety and efficacy of Actemra / RoActemra (tocilizumab) plus standard of care in hospitalised adult patients with severe COVID-19 pneumonia compared to placebo plus standard of care.

This is the first global study of Actemra / RoActemra in this setting and is expected to begin enrolling as soon as possible in early April with a target of approximately 330 patients globally, including the US. The primary and secondary endpoints include clinical status, mortality, mechanical ventilation and intensive care unit (ICU) variables.

"We are initiating a clinical trial to study Actemra / RoActemra for the treatment of people hospitalised with COVID-19 pneumonia, so that we can better establish the potential role for Actemra / RoActemra in fighting this disease," said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “In these unprecedented times, today’s announcement is an important example of how industry and regulators can collaborate quickly to address the COVID-19 pandemic, and we will share the results as soon as possible.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/253062 .

Major Points in Table of Contents:

Global mRNA Sequencing Market Report 2020

1 mRNA Sequencing Product Definition

2 Global mRNA Sequencing Market Manufacturer Share and Market Overview

2.1 Global Manufacturer mRNA Sequencing Shipments

2.2 Global Manufacturer mRNA Sequencing Business Revenue

2.3 Global mRNA Sequencing Market Overview

3 Manufacturer mRNA Sequencing Business Introduction

3.1 Thermo Fisher Scientific mRNA Sequencing Business Introduction

3.2 Illumina mRNA Sequencing Business Introduction

3.3 QIAGEN (Exiqon) mRNA Sequencing Business Introduction

3.4 Agilent Technologies mRNA Sequencing Business Introduction

3.5 Roche mRNA Sequencing Business Introduction

3.6 GE Healthcare mRNA Sequencing Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.